We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USEG:NASDAQU.S. Energy Corp. Analysis

Data as of 2026-06-16 - not real-time

$0.99

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Big Sky Industrial Inc. (formerly U.S. Energy Corp.) is navigating a pivotal transition, highlighted by a recent rebrand that aligns the company with a new helium production and carbon‑management strategy. Technical indicators show a neutral market stance: the 20‑day moving average sits just above the current price, the RSI hovers just above the 50 midpoint, and the MACD histogram is marginally negative, suggesting limited short‑term upside. Fundamentally, the firm faces significant challenges—negative earnings, operating cash flow deficits, and a high debt‑to‑equity ratio—yet the forward price‑to‑earnings multiple is in the mid‑teens and the price‑to‑book ratio is modest, implying potential undervaluation relative to its projected recovery.
The market’s “Extreme Greed” sentiment and a sizable upside/downside estimate reinforce the view that the stock may be priced below its longer‑term target of roughly $2.75. Investors should weigh the upside from the strategic shift against the considerable financial and operational risks before deciding on entry timing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical stance with price below short‑term SMA
  • Recent rebrand may need time to translate into price action
  • High short‑term volatility and bearish MACD signal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic shift toward helium and carbon management offers growth runway
  • Forward PE in the mid‑teens suggests reasonable valuation relative to earnings recovery
  • Increasing volume indicates growing investor interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term upside potential tied to integrated industrial gas and carbon‑capture markets
  • Undervalued price relative to target valuation and sector fundamentals
  • Low beta reflects limited market‑wide correlation, allowing company‑specific catalysts to drive returns

Key Metrics & Analysis

Financial Health

Revenue Growth-27.90%
Profit Margin-231.43%
P/E Ratio16.4
ROE-40.12%
ROA-15.77%
Debt/Equity7.45
P/B Ratio1.4
Op. Cash Flow$-5046000
Free Cash Flow$-16832500

Technical Analysis

TrendNeutral
RSI51.5
Support$0.86
Resistance$1.19
MA 20$1.00
MA 50$0.94
MA 200$1.04
MACDBearish
VolumeIncreasing
Fear & Greed Index92.5

Valuation

Target Price$2.75
Upside/Downside179.07%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.00
Volatility72.92%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.